Professional Documents
Culture Documents
Anggraini PPFA Farmasi 2023 Rev
Anggraini PPFA Farmasi 2023 Rev
Slide Anggi
Outline
Slide Anggi
# Seorang anak perempuan usia 15 tahun datang dengan
keluhan demam dan nyeri menelan
Slide Anggi
Slide Anggi
Slide Anggi
• Proportion:
• surgical (23%)
• medical prophylaxis (10%): gastrointestinal surgery
• Prolonged (>1 day) surgical prophylaxis: 76%
Most common
diagnosis for systemic
antibiotic use
● Matlock A, Garcia JA, Moussavi K, Long B, Liang SYT. Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections. Vol. 16, Internal and Emergency Medicine. Springer Science and Business Media Deutschland GmbH; 2021. p. 2231–41.
● Parmanik A, Das S, Kar B, Bose A, Dwivedi GR, Pandey MM. Current Treatment Strategies Against Multidrug-Resistant Bacteria: A Review. Vol. 79, Current Microbiology. Springer; 2022.
● Khalili H, Izadpanah M. Antibiotic regimens for treatment of infections due to multidrug-resistant Gram-negative pathogens: An evidence-based literature review. J Res Pharm Pract. 2015;4(3):105.
● Giurazza R, Mazza MC, Andini R, Sansone P, Pace MC, Durante-Mangoni E. Emerging treatment options for multi-drug-resistant bacterial infections. Life. 2021 Jun 1;11(6).
● Bassetti M, Peghin M, Vena A, Giacobbe DR. Treatment of Infections Due to MDR Gram-Negative Bacteria. Vol. 6, Frontiers in Medicine. Frontiers Media S.A.; 2019.
Dampak resistensi antimikroba
Slide Anggi
WHO, 2017
Structure of Gram-negative bacteria and their mechanisms of resistance
Slide Anggi
Data Surveilans AMR Nasional yang disubmit ke platform Global Antimicrobial Resistance Surveillance System(GLASS) WHO
Regulasi terkait PPRA
Slide Anggi
Slide Anggi
Definisi Penatagunaan Antimikroba
Slide Anggi
Program Utama PPRA
Slide Anggi
Strategi pengendalian resistensi antimikroba
Slide Anggi
Slide Anggi
Tujuan Program Penatalayanan Antimikroba
Tujuan Umum.
• Melaksanakan penatalayanan antimikroba secara bijak.
Tujuan Khusus.
• Melaksanakan restriksi dan preotorisasi penatalayanan/peresepan antimikroba.
• Optimasi penggunaan terapi antimikroba.
• Meningkatkan kualitas terapi antimikroba.
• Melaksanakan audit prospektif, intervensi dan umpan balik serta edukasi.
• Mengurangi lama perawatan.
• Mengurangi laju resistensi antimikroba.
Slide Anggi
Struktur Organisasi PPRA
Slide Anggi
Slide Anggi
Slide Anggi
Slide Anggi
Komponen SDM PPRA
Ketua Tim PPRA Konsultan Infeksi
Slide Anggi
The rationale used for
antibiotic choice
Apus Gram
kokus positif
Slide Anggi
Slide Anggi
Slide Anggi
Slide Anggi
Standar Akreditasi terkait PPRA
Slide Anggi
Indikator mutu PPRA (PMK no.8/2015, pasal 11)
Slide Anggi
Slide Anggi
Target
Nasional
Slide Anggi
# Seorang anak perempuan usia 15 tahun datang dengan keluhan
demam dan nyeri menelan
# Apakah perlu diberikan antibiotik?
Slide Anggi
Kesimpulan
Slide Anggi